Highlights Roche Holding AG BOERSE MUENCHEN

Equities

RHO

CH0012032113

Real-time BOERSE MUENCHEN Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-.--%

06-27	Roche: WHO prequalification for HPV testing	CF
06-27	Roche Receives Additional Prequalification Designations for HPV Test	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Roche Receives Additional Prequalification Designations for HPV Test	06-27	MT
Roche Wins EU Nod for Subcutaneous Formula of Multiple Sclerosis Drug Ocrevus	06-25	MT
Halozyme Therapeutics, Inc. Announces Roche's OCREVUS SC with ENHANZE Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis	06-25	CI
Roche Announces the European Commission Grants Marketing Authorisation for OCREVUS (Ocrelizumab) Subcutaneous for the Treatment of Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis	06-25	CI
Global markets live: Novo Nordisk, Apple, UPS, Eli Lilly, Qualcomm...	06-24
Foreign banks target Switzerland after UBS takeover of Credit Suisse	06-24	RE
Roche: two new units for cobas pro	06-24	CF
European Medicines Agency Begins Review of Roche's Gene Therapy for Duchenne Muscular Dystrophy	06-24	MT
US FDA approves Roche's drug for a chronic blood disorder	06-21	RE
Sarepta Therapeutics Gets Expanded Label FDA Approval for Duchenne Muscular Dystrophy; Shares Soar Premarket	06-21	MT
Sarepta Therapeutics Gets Expanded US FDA Approval for Treatment of Duchenne Muscular Dystrophy; Shares Soar After Hours	06-20	MT
US FDA approves expanded use of Sarepta's Duchenne gene therapy; shares jump	06-20	RE
Sarepta Shares Soar 37% Following Expanded Approval for Elevidys	06-20	DJ
Sarepta Therapeutics, Inc. Announces Expanded US FDA Approval of Eletidys to Duchenne Muscular Dystrophy Patients Ages 4 and Above	06-20	CI
Swiss Equities Close Higher as SNB Delivers Another Rate Cut	06-20	MT
Roche: new detection test for lymphoma	06-20	CF
Roche Launches First Clinically Approved Test for B-cell Lymphoma	06-20	MT
Roche Launches New Highly-Sensitive Test to More Easily Diagnostic Patients Who May Have B-Cell Lymphoma	06-20	CI
Roche: collaboration agreement with Ascidian Therapeutics	06-18	CF
Roche Teams Up With Ascidian Therapeutics for RNA Gene Editing Deal	06-18	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 04:50 pm

Obesity: Roche joins the battle

December 04, 2023 at 03:48 pm